Literature DB >> 26361349

Zebrafish as tools for drug discovery.

Calum A MacRae1,2,3,4, Randall T Peterson3,4,5,6.   

Abstract

The zebrafish has become a prominent vertebrate model for disease and has already contributed to several examples of successful phenotype-based drug discovery. For the zebrafish to become useful in drug development more broadly, key hurdles must be overcome, including a more comprehensive elucidation of the similarities and differences between human and zebrafish biology. Recent studies have begun to establish the capabilities and limitations of zebrafish for disease modelling, drug screening, target identification, pharmacology, and toxicology. As our understanding increases and as the technologies for manipulating zebrafish improve, it is hoped that the zebrafish will have a key role in accelerating the emergence of precision medicine.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26361349     DOI: 10.1038/nrd4627

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  104 in total

1.  High-throughput assay for small molecules that modulate zebrafish embryonic heart rate.

Authors:  C Geoffrey Burns; David J Milan; Eric J Grande; Wolfgang Rottbauer; Calum A MacRae; Mark C Fishman
Journal:  Nat Chem Biol       Date:  2005-09-18       Impact factor: 15.040

2.  Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats.

Authors:  Igor Theurl; Andrea Schroll; Thomas Sonnweber; Manfred Nairz; Milan Theurl; Wolfgang Willenbacher; Kathrin Eller; Dominik Wolf; Markus Seifert; Chia Chi Sun; Jodie L Babitt; Charles C Hong; Tracey Menhall; Patrick Gearing; Herbert Y Lin; Guenter Weiss
Journal:  Blood       Date:  2011-07-05       Impact factor: 22.113

3.  A novel chemical screening strategy in zebrafish identifies common pathways in embryogenesis and rhabdomyosarcoma development.

Authors:  Xiuning Le; Emily K Pugach; Simone Hettmer; Narie Y Storer; Jianing Liu; Airon A Wills; Antony DiBiase; Eleanor Y Chen; Myron S Ignatius; Kenneth D Poss; Amy J Wagers; David M Langenau; Leonard I Zon
Journal:  Development       Date:  2013-04-24       Impact factor: 6.868

4.  Selective small molecule targeting β-catenin function discovered by in vivo chemical genetic screen.

Authors:  Jijun Hao; Ada Ao; Li Zhou; Clare K Murphy; Audrey Y Frist; Jessica J Keel; Curtis A Thorne; Kwangho Kim; Ethan Lee; Charles C Hong
Journal:  Cell Rep       Date:  2013-09-05       Impact factor: 9.423

5.  Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation.

Authors:  Andrea U Steinbicker; Chetana Sachidanandan; Ashley J Vonner; Rushdia Z Yusuf; Donna Y Deng; Carol S Lai; Kristen M Rauwerdink; Julia C Winn; Borja Saez; Colleen M Cook; Brian A Szekely; Cindy N Roy; Jasbir S Seehra; Gregory D Cuny; David T Scadden; Randall T Peterson; Kenneth D Bloch; Paul B Yu
Journal:  Blood       Date:  2011-03-10       Impact factor: 22.113

6.  Functional conservation of erythropoietin signaling in zebrafish.

Authors:  Noëlle Paffett-Lugassy; Nelson Hsia; Paula G Fraenkel; Barry Paw; Irene Leshinsky; Bruce Barut; Nathan Bahary; Jaime Caro; Robert Handin; Leonard I Zon
Journal:  Blood       Date:  2007-06-19       Impact factor: 22.113

7.  Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish.

Authors:  T Cameron Tran; Blossom Sneed; Jamil Haider; Delali Blavo; Audrey White; Temitope Aiyejorun; Timothy C Baranowski; Amy L Rubinstein; Thanh N Doan; Raymond Dingledine; Eric M Sandberg
Journal:  Cancer Res       Date:  2007-12-01       Impact factor: 12.701

8.  Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation.

Authors:  Corey Cutler; Pratik Multani; David Robbins; Haesook T Kim; Thuy Le; Jonathan Hoggatt; Louis M Pelus; Caroline Desponts; Yi-Bin Chen; Betsy Rezner; Philippe Armand; John Koreth; Brett Glotzbecker; Vincent T Ho; Edwin Alyea; Marlisa Isom; Grace Kao; Myriam Armant; Leslie Silberstein; Peirong Hu; Robert J Soiffer; David T Scadden; Jerome Ritz; Wolfram Goessling; Trista E North; John Mendlein; Karen Ballen; Leonard I Zon; Joseph H Antin; Daniel D Shoemaker
Journal:  Blood       Date:  2013-08-30       Impact factor: 22.113

9.  Identification of Chemical Inhibitors of β-Catenin-Driven Liver Tumorigenesis in Zebrafish.

Authors:  Kimberley J Evason; Macrina T Francisco; Vladislava Juric; Sanjeev Balakrishnan; Maria Del Pilar Lopez Pazmino; John D Gordan; Sanjay Kakar; Jan Spitsbergen; Andrei Goga; Didier Y R Stainier
Journal:  PLoS Genet       Date:  2015-07-02       Impact factor: 5.917

10.  Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet syndrome treatment.

Authors:  Scott C Baraban; Matthew T Dinday; Gabriela A Hortopan
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  283 in total

1.  Organoruthenium(II) Complexes Bearing an Aromatase Inhibitor: Synthesis, Characterization, in Vitro Biological Activity and in Vivo Toxicity in Zebrafish Embryos.

Authors:  Golara Golbaghi; Mohammad Mehdi Haghdoost; Debbie Yancu; Yossef López de Los Santos; Nicolas Doucet; Shunmoogum A Patten; J Thomas Sanderson; Annie Castonguay
Journal:  Organometallics       Date:  2019-01-31       Impact factor: 3.876

2.  ScreenCube: A 3D Printed System for Rapid and Cost-Effective Chemical Screening in Adult Zebrafish.

Authors:  Adrian T Monstad-Rios; Claire J Watson; Ronald Y Kwon
Journal:  Zebrafish       Date:  2017-10-30       Impact factor: 1.985

3.  Zebrafish have an ethanol-inducible hepatic 4-nitrophenol hydroxylase that is not CYP2E1-like.

Authors:  Jessica H Hartman; Jordan S Kozal; Richard T Di Giulio; Joel N Meyer
Journal:  Environ Toxicol Pharmacol       Date:  2017-07-10       Impact factor: 4.860

4.  Synchrotron microCT imaging of soft tissue in juvenile zebrafish reveals retinotectal projections.

Authors:  Xuying Xin; Darin Clark; Khai Chung Ang; Damian B van Rossum; Jean Copper; Xianghui Xiao; Patrick J La Riviere; Keith C Cheng
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2017-03-03

5.  Acute toxicity and teratogenicity of α-mangostin in zebrafish embryos.

Authors:  Wannakarn Kittipaspallop; Pornnarin Taepavarapruk; Chanpen Chanchao; Wittaya Pimtong
Journal:  Exp Biol Med (Maywood)       Date:  2019-01-02

6.  Development of a high-throughput in vivo screening platform for particulate matter exposures.

Authors:  Courtney Roper; Staci L Massey Simonich; Robert L Tanguay
Journal:  Environ Pollut       Date:  2018-02-21       Impact factor: 8.071

7.  An orthotopic glioblastoma animal model suitable for high-throughput screenings.

Authors:  Linda Pudelko; Steven Edwards; Mirela Balan; Daniel Nyqvist; Jonathan Al-Saadi; Johannes Dittmer; Ingrid Almlöf; Thomas Helleday; Lars Bräutigam
Journal:  Neuro Oncol       Date:  2018-10-09       Impact factor: 12.300

8.  Mass spectrometry imaging in zebrafish larvae for assessing drug safety and metabolism.

Authors:  Mariana Asslan; Nidia Lauzon; Maja Beus; Dusica Maysinger; Simon Rousseau
Journal:  Anal Bioanal Chem       Date:  2021-06-26       Impact factor: 4.142

9.  Early vertebrate origin and diversification of small transmembrane regulators of cellular ion transport.

Authors:  Sergej Pirkmajer; Henriette Kirchner; Leonidas S Lundell; Pavel V Zelenin; Juleen R Zierath; Kira S Makarova; Yuri I Wolf; Alexander V Chibalin
Journal:  J Physiol       Date:  2017-05-29       Impact factor: 5.182

Review 10.  Animal Models for the Study of Nucleic Acid Immunity: Novel Tools and New Perspectives.

Authors:  Isabelle K Vila; Maxence Fretaud; Dimitrios Vlachakis; Nadine Laguette; Christelle Langevin
Journal:  J Mol Biol       Date:  2020-08-26       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.